Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants.
Jay Rubinstein, MD, PhD
Advertisement
Articles by Jay Rubinstein, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Cariprazine improves mania and depression in pediatric bipolar I
2
How pediatricians can reframe vaccine conversations
3
Exploring AhR agonists in pediatric atopic dermatitis
4
FDA investigates malignancy risk with SMA gene therapy Zolgensma
5